The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Rhythm Pharmaceuticals, Inc(NASDAQ:RYTM) 
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...
Website: http://www.rhythmtx.com
Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
Rhythm Pharmaceuticals Days Payable Outstanding ttm (DPO)
Rhythm Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Rhythm Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Rhythm Pharmaceuticals Op Cashflow Per Share ttm
Rhythm Pharmaceuticals Free Cashflow Per Share ttm
Rhythm Pharmaceuticals Cash Per Share ttm
Rhythm Pharmaceuticals P/S ratio ttm
Rhythm Pharmaceuticals (GAAP) P/E ratio ttm
Rhythm Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.